These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 26739469)
21. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes. Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients. Zhao ZK; Yu HF; Wang DR; Dong P; Chen L; Wu WG; Ding WJ; Liu YB World J Gastroenterol; 2012 Dec; 18(45):6651-6. PubMed ID: 23236241 [TBL] [Abstract][Full Text] [Related]
23. [Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]. Zhao YN; Cao J; Wu FX; Ou C; Yuan WP; Mo QG; Wei W; Li Y; Su JJ; Liang AM Ai Zheng; 2004 Jul; 23(7):762-6. PubMed ID: 15248908 [TBL] [Abstract][Full Text] [Related]
24. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma. Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma. Cha HJ; Kim J; Hong SM; Hong SJ; Park JH; Kim ES; Wang HJ; Choi YJ; Do IG; Joh JW; Kim DS; Choi KY Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S404-11. PubMed ID: 21717246 [TBL] [Abstract][Full Text] [Related]
26. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma. Li B; Shao Q; Ji D; Li F; Guo X; Chen G Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637 [TBL] [Abstract][Full Text] [Related]
27. Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma. Yang W; Lv S; Liu X; Liu H; Yang W; Hu F Jpn J Clin Oncol; 2010 Nov; 40(11):1053-9. PubMed ID: 20522449 [TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma. Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360 [TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological significance of ezrin and SIX1 protein expression in alpha fetoprotein-negative hepatocellular carcinoma]. Kong J; Zhou X; Han L; Quan C; Cui X; Lin Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):236-9. PubMed ID: 26927385 [TBL] [Abstract][Full Text] [Related]
30. Decreased expression of PTH1R is a poor prognosis in hepatocellular carcinoma. Wang HJ; Wang L; Song SS; He XL; Pan HY; Hu ZM; Mou XZ Cancer Biomark; 2018 Feb; 21(3):723-730. PubMed ID: 29278884 [TBL] [Abstract][Full Text] [Related]
31. CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma. Li Y; Yu HP; Zhang P Hepatol Int; 2016 May; 10(3):488-92. PubMed ID: 26643668 [TBL] [Abstract][Full Text] [Related]
32. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. Yin F; Han X; Yao SK; Wang XL; Yang HC World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422 [TBL] [Abstract][Full Text] [Related]
33. [Expression and clinical significance of soluble B7-H3 in sera of patients with primary hepatocellular carcinoma]. Wang F; Yu G; Liu T; Wang G; Yang J; Zhang G; Luan X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):629-32. PubMed ID: 23746248 [TBL] [Abstract][Full Text] [Related]
34. Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma. Huang X; Qu P; Chen Y; Zhou X; Wu Y; Liu F; Wang D; Zhang J; An J Hum Pathol; 2014 Sep; 45(9):1944-50. PubMed ID: 25081539 [TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection. Zhang ZF; Feng XS; Chen H; Duan ZJ; Wang LX; Yang D; Liu PX; Zhang QP; Jin YL; Sun ZG; Liu H BMC Gastroenterol; 2016 Jun; 16(1):57. PubMed ID: 27255554 [TBL] [Abstract][Full Text] [Related]
36. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma. Zhang S; Li J; Wang X Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614 [TBL] [Abstract][Full Text] [Related]
37. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma. Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma. Liao W; Liu W; Liu X; Yuan Q; Ou Y; Qi Y; Huang W; Wang Y; Huang J Oncotarget; 2015 Sep; 6(27):24132-47. PubMed ID: 26125229 [TBL] [Abstract][Full Text] [Related]
39. [PTEN expression and its significance in human primary hepatocellular carcinoma]. Wan XW; Wang HY; Jiang M; He YQ; Liu SQ; Cao HF; Qiu XH; Tang L; Wu MC Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):490-2. PubMed ID: 12939185 [TBL] [Abstract][Full Text] [Related]
40. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]